Health Professional Radio - Podcast

Gyula Kangiszar, President, RotChrom Technologies North America, developers of the first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, discusses the partnership with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. ("Cyclolab") aimed at developing a more efficient and cost-effective process to purify Remdesivir, a direct-acting antiviral agent approved in countries around the world to treat patients with severe cases of COVID-19. Gyula Kangiszar, President RotaChrom Technologies North America. Gyula is a seasoned strategy and innovation consultant with over 25 years of international experience working for Deloitte, Accenture, Microsoft and EY. He advised leading corporations on a wide range of topics from market strategy through purposeful transformation to operations improvement. Gyula started his career by co-founding and successfully growing a software development company. As the leader of RotaChrom’s North American subsidiary, Gyula is responsible for scali